Sumagang, Jerick .
HRN: 22-44-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/18/2023
02/25/2023
IV
68 Mg
Q24
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Disseminated Systemic InfectionUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes